J
Jacek Zdybski
Publications - 2
Citations - 208
Jacek Zdybski is an academic researcher. The author has contributed to research in topics: Atopic dermatitis & Randomized controlled trial. The author has an hindex of 1, co-authored 2 publications receiving 26 citations.
Papers
More filters
Journal ArticleDOI
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Thomas Bieber,Eric L. Simpson,Jonathan I. Silverberg,Diamant Thaçi,Carle Paul,Andrew Pink,Yoko Kataoka,Chia-Yu Chu,Marco DiBonaventura,Ricardo Rojo,Jeremias Antinew,Ileana A. Ionita,Rodney Sinclair,Seth Forman,Jacek Zdybski,Pinaki Biswas,Bimal Malhotra,Fan Zhang,Hernan Valdez +18 more
TL;DR: In this article, the oral Janus kinase 1 (JAK1) inhibitor abrocitinib, which reduces interleukin-4 and interleucin-13 signaling, was investigated for the treatment of atopic dermatitis.
Journal ArticleDOI
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.
Andrew Blauvelt,Jonathan I. Silverberg,Charles Lynde,Thomas Bieber,Samantha Eisman,Jacek Zdybski,Walter Gubelin,Eric L. Simpson,Fernando Valenzuela,Paulo Ricardo Criado,Mark Lebwohl,Claire Feeney,Tahira Khan,Pinaki Biswas,Marco DiBonaventura,Hernan Valdez,Michael C. Cameron,Ricardo Rojo +17 more
TL;DR: In this paper, the authors evaluated the maintenance of abrocitinib-induced atopic dermatitis response with continuous AbROCITINIB treatment, dose reduction or withdrawal, and response to treatment reintroduction following flare.